Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis
Authors:
- Alexander KappAKAlexander Kapp
- Giselda ColomboGCGiselda Colombo
- Jan G.R. de MonchyJMJan G.R. de Monchy
- Sabina RakSRSabina Rak
- Waltraud EmmingerWEWaltraud Emminger
- Montserrat Fernández RivasMRMontserrat Fernández Rivas
- Mette RibelMRMette Ribel
- Stephen R. DurhamSDStephen R. Durham
Top Cited Papers
- 1 August 2006
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 118 (2) , 434-440
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitisJournal of Allergy and Clinical Immunology, 2006
- Safety of a SQ‐standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo‐controlled trialAllergy, 2006
- Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitisAllergy, 2006
- Sublingual immunotherapy for allergic rhinitis: systematic review and meta‐analysis*Allergy, 2004
- Mechanisms of immunotherapyJournal of Allergy and Clinical Immunology, 2004
- Oral and sublingual immunotherapy in paediatric patientsCurrent Opinion in Allergy and Clinical Immunology, 2003
- Is sublingual immunotherapy clinically effective?Current Opinion in Allergy and Clinical Immunology, 2002
- Grass pollen immunotherapy for seasonal rhinitis and asthma: A randomized, controlled trialJournal of Allergy and Clinical Immunology, 2001
- Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy?Clinical & Experimental Allergy, 1998
- Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in childrenJournal of Allergy and Clinical Immunology, 1997